Back to mobile site

Cyclacel Pharma (CYCC) Misses Q4 EPS by 33c

April 3, 2025 6:55 AM EDT

Cyclacel Pharma (NASDAQ: CYCC) reported Q4 EPS of ($0.33).

For earnings history and earnings-related data on Cyclacel Pharma (CYCC) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings, Maynard Um, Mark Zuckerberg, ARK